Seetharamaiah G S, Desai R K, Dallas J S, Tahara K, Kohn L D, Prabhakar B S
Department of Microbiology, University of Texas Medical Branch, Galveston 77555.
Autoimmunity. 1993;14(4):315-20. doi: 10.3109/08916939309079234.
A cDNA encoding the extracellular domain of human TSHr (ETSHr) was expressed in large quantities using the baculovirus expression system. Maximum level of protein was produced at 60 hr post-infection and represented approximately 20% of the total cellular protein. The identity of the protein as ETSHr was confirmed by Western blot using antibodies to synthetic peptides derived from the TSHr. The protein has an apparent molecular weight of 50 kDa and is larger than the predicted size of 44 kDa, suggesting that the protein is glycosylated. Polyclonal antibodies raised in rabbits against gel purified ETSHr blocked the binding of 125I-TSH to native TSHr in solubilized porcine thyroid membranes in a radioreceptor assay. The availability of this antigenically active protein will facilitate further characterization of the protein and analysis of immune response against TSHr in experimental animals as well as in patients with autoimmune Graves' disease.
利用杆状病毒表达系统大量表达了编码人促甲状腺激素受体(TSHr)胞外结构域的cDNA。感染后60小时产生的蛋白质水平最高,约占细胞总蛋白的20%。使用针对源自TSHr的合成肽的抗体,通过蛋白质印迹法确认了该蛋白质为ETSHr。该蛋白质的表观分子量为50 kDa,大于预测的44 kDa大小,表明该蛋白质进行了糖基化。用兔制备的针对凝胶纯化的ETSHr的多克隆抗体,在放射受体分析中阻断了125I-TSH与溶解的猪甲状腺膜中天然TSHr的结合。这种具有抗原活性的蛋白质的可得性将有助于进一步表征该蛋白质,并分析实验动物以及自身免疫性格雷夫斯病患者针对TSHr的免疫反应。